Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dependence01:17

Drug Dependence

1.9K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

642
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
642
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

342
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
342
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

610
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
610
Modeling in Therapy01:26

Modeling in Therapy

823
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
823

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of telehealth and in-person delivery of alcohol behavioral couple therapy.

Journal of substance use and addiction treatment·2026
Same author

First-in-human nuclease-free homologous recombination-dependent gene editing in pediatric patients with methylmalonic acidemia: results of a phase 1/2 study.

Gene therapy·2026
Same author

Characterizing the frequency of clinical events and assessing biomarkers in propionic acidemia: a natural history study.

Orphanet journal of rare diseases·2026
Same author

Randomized Trial Shows Smartphone Support App for DWI Offenders and Their Families Reduced Alcohol Use and Ignition Interlock Device Lockouts.

Journal of studies on alcohol and drugs·2025
Same author

Women and alcohol: A call to action.

Alcohol, clinical & experimental research·2025
Same author

Results of a Randomized Controlled Trial Examining the Efficacy of Intranasal Oxytocin to Enhance Alcohol Behavioral Couple Therapy.

The Journal of clinical psychiatry·2025

Related Experiment Video

Updated: May 4, 2026

Novel Apparatus and Method for Drug Reinforcement
07:32

Novel Apparatus and Method for Drug Reinforcement

Published on: August 21, 2010

21.5K

Need-Service Matching Predicts Drug Use Outcomes in Comprehensive Treatment for Mothers with Substance Use Disorder

Kristina N Rynes1, Barbara S McCrady1,2, Thomas Morgan2,3

  • 1Now at: Center on Alcohol, Substance use, and Addictions (CASAA), University of New Mexico, Albuquerque, New Mexico, USA.

Substance Use & Misuse
|March 1, 2026
PubMed
Summary

Tailoring substance use disorder (SUD) treatment to women's family, employment, and psychiatric needs improved outcomes. Specific women-centered services did not predict abstinence but did increase drug use days for those still using.

Keywords:
Comprehensive servicesdependent childrenneed-service matchingsubstance use disorder treatmentwomen

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

11.3K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

813

Related Experiment Videos

Last Updated: May 4, 2026

Novel Apparatus and Method for Drug Reinforcement
07:32

Novel Apparatus and Method for Drug Reinforcement

Published on: August 21, 2010

21.5K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

11.3K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

813

Area of Science:

  • Addiction Medicine
  • Psychiatry
  • Social Work

Background:

  • Substance use disorder (SUD) treatment effectiveness is enhanced by client-specific interventions.
  • Limited research exists on SUD treatment for women within the child protection system.

Purpose of the Study:

  • To evaluate the impact of tailored SUD treatment on women with dependent children.
  • To assess the efficacy of women-specific interventions and integrated care for family, employment, and psychiatric needs.

Main Methods:

  • A pre-post evaluation design was used with 246 women in comprehensive SUD treatment programs.
  • The Addiction Severity Index (ASI) was utilized to measure treatment needs and outcomes at 6-month follow-up.
  • Zero-inflated Poisson regressions analyzed substance use patterns post-treatment.

Main Results:

  • Abstinence rates were not significantly predicted by treatment-as-usual (TAU) or women-specific services.
  • For women continuing substance use, more women-specific services correlated with increased drug use days.
  • Treatment addressing family, employment, and psychiatric needs predicted fewer drug use days among active users.
  • Increased psychiatric service utilization was linked to more drug use days in women with initially low psychiatric needs.

Conclusions:

  • Matching SUD treatment services to the multifaceted needs of women with dependent children may improve substance use outcomes.
  • The study highlights the importance of integrated care but suggests caution with specific service delivery models for certain populations.